Blue Jay Capital Management as of Dec. 31, 2015
Portfolio Holdings for Blue Jay Capital Management
Blue Jay Capital Management holds 23 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Intuitive Surgical (ISRG) | 6.8 | $20M | 37k | 546.16 | |
| Edwards Lifesciences (EW) | 6.7 | $20M | 253k | 78.98 | |
| Shire | 6.4 | $19M | 92k | 205.00 | |
| Biogen Idec (BIIB) | 6.0 | $18M | 58k | 306.36 | |
| Endo International (ENDPQ) | 5.3 | $16M | 255k | 61.22 | |
| Baxalta Incorporated | 5.1 | $15M | 385k | 39.03 | |
| Cerner Corporation | 4.4 | $13M | 216k | 60.17 | |
| Nevro (NVRO) | 4.3 | $13M | 190k | 67.51 | |
| Hologic (HOLX) | 4.2 | $13M | 326k | 38.69 | |
| Impax Laboratories | 4.2 | $13M | 295k | 42.76 | |
| Quest Diagnostics Incorporated (DGX) | 4.2 | $13M | 175k | 71.14 | |
| Cooper Companies | 4.1 | $12M | 90k | 134.20 | |
| Agilent Technologies Inc C ommon (A) | 4.0 | $12M | 285k | 41.81 | |
| Bristol Myers Squibb (BMY) | 3.8 | $11M | 165k | 68.79 | |
| Neurocrine Biosciences (NBIX) | 3.8 | $11M | 200k | 56.57 | |
| Wright Medical Group Nv | 3.7 | $11M | 450k | 24.18 | |
| Cepheid | 3.6 | $11M | 290k | 36.53 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.4 | $10M | 80k | 125.83 | |
| Qiagen | 3.4 | $10M | 360k | 27.65 | |
| DepoMed | 3.3 | $9.7M | 535k | 18.13 | |
| Perrigo Company (PRGO) | 3.2 | $9.5M | 66k | 144.70 | |
| St. Jude Medical | 3.2 | $9.4M | 153k | 61.77 | |
| Masimo Corporation (MASI) | 3.0 | $8.9M | 215k | 41.51 |
